Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Current Diabetes Reviews(1)
Current Nutrition and Food Science(1)
Current Pharmaceutical Design(1)
Frontiers in Endocrinology(1)
International Journal of Molecular Sciences(1)
Área temáticas
Enfermedades(6)
Fisiología humana(6)
Salud y seguridad personal(2)
Alimentación y bebidas(1)
Biología(1)
Clinical and nutritional implications of kidney disease and COVID-19
ReviewAbstract: By the end of 2019 emerged a cluster of pneumonia that was caused by a novel SARS-CoV-2 virus. The dPalabras claves:acute kidney injury, Chronic kidney disease, Clinical nutrition, covid-19, nutritional, SARS-COV-2Autores:Albornoz C., Ariza D., Carrasquero R., D’marco L., Guerra-Torres X.E., Morillo V., Nava M., Valmore Bermúdez, Vasquez H.E.A.Fuentes:scopusAge-specific waist circumference cutoff-points for abdominal obesity diagnosis: a personalized strategy for a large Venezuelan population
ArticleAbstract: Background: Evidence shows that the ageing process is a determining factor in fat distribution, compPalabras claves:aging, Coronary artery disease, Hypertension, Metabolic syndrome, obesity, Waist circumferenceAutores:Añez-Ramos R., Cano-Ponce C., D’marco L., González M.C., Martínez M.S., Nava M., Olivar L.C., Ortega A., Rodriguez J.E., Rojas M.P., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Valmore BermúdezFuentes:scopusPerirenal fat thickness is associated with metabolic risk factors in patients with chronic kidney disease
ArticleAbstract: Background: Adipose tissue accumulation in specific body compartments has been associated with diabePalabras claves:Cardiovascular, Chronic kidney disease, DIABÉTES, Metabolic risk, Perirenal fat, Renal InsufficiencyAutores:Cortez M., D’marco L., Lima-Martínez M., Rojas E.R., Roque W., Salazar M., Salazar-Vílchez J., Valmore Bermúdez, Wettel M.Fuentes:scopusIs “leptin resistance” another key resistance to manage type 2 diabetes?
ReviewAbstract: Although novel pharmacological options for the treatment of type 2 diabetes mellitus (DM2) have beenPalabras claves:Adipokines, DIABÉTES, Hyperleptinemia, Insulin Resistance, leptin, Leptin resistance, obesityAutores:Chávez-Castillo M., Cristobal Ignacio Espinoza Díaz, Dávila L.C.A., D’marco L., González M.C., Herazo Y., Nava M., Ortega A., Pérez J.L., Rojas M., Rojas-Gómez D.M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:googlescopusThe Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium
ReviewAbstract: Adipose tissue (AT) biology is linked to cardiovascular health since obesity is associated with cardPalabras claves:adipose tissue, inflammation, microbiota, myocardiocytes, obesityAutores:Cabrera De Bravo M.C., Carrasquero R., Diaz M.P., Durán P., D’marco L., González M.C., Nava M., Ponce C.C., Rivas J., Rojas E.R., Teruel J.L., Valmore BermúdezFuentes:scopusThe role of the α cell in the pathogenesis of diabetes: A world beyond the mirror
ReviewAbstract: Type 2 Diabetes Mellitus (T2DM) is one of the most prevalent chronic metabolic disorders, and insuliPalabras claves:glucagon, Hyperglycaemia, Hypoglycaemia, Langerhans’ islets, Type 2 DiabetesAutores:Cabrera De Bravo M.C., Cano-Ponce C., Dávila L.C.A., D’marco L., González M.C., Guerrero-Wyss M., Manzano A., Martínez M.S., Nava M., Olivar L.C., Rina Ortiz, Salazar-Vílchez J., Valmore BermúdezFuentes:scopusRole of dietary polyphenols in adipose tissue browning: A narrative review
ReviewAbstract: Lifestyle modifications such as energy restriction and increased physical activity are highly effectPalabras claves:Adipose tissue browning, energy expenditure, Nutraceuticals, obesity, Polyphenols, ThermogenesisAutores:Cano-Ponce C., Carrasquero R., Castro A., Diaz M.P., D’marco L., Garrido B., González M.C., Pérez J.L., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusSGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
ReviewAbstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) aPalabras claves:Autores:D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.Fuentes:scopus